Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.

Targeted delivery of antigens to dendritic cells (DCs) is a promising vaccination strategy. However, to ensure immunity, the approach depends on coadministration of an adjuvant. Here we ask whether targeting of both adjuvant and antigen to DCs is sufficient to induce immunity. Using a protein ligation method, we develop a general approach for linking the immune stimulant, poly dA:dT (pdA:dT), to a monoclonal antibody (mAb) specific for DEC205 (DEC). We show that DEC-specific mAbs deliver pdA:dT to DCs for the efficient production of type I interferon in human monocyte-derived DCs and in mice. Notably, adaptive T-cell immunity is elicited when mAbs specific for DEC-pdA:dT are used as the activation stimuli and are administered together with a DC-targeted antigen. Collectively, our studies indicate that DCs can integrate innate and adaptive immunity in vivo and suggest that dual delivery of antigen and adjuvant to DCs might be an efficient approach to vaccine development.

[1]  R. Steinman,et al.  Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. , 1995, Cellular immunology.

[2]  C. Niemeyer,et al.  Combination of DNA-directed immobilization and immuno-PCR: very sensitive antigen detection by means of self-assembled DNA-protein conjugates. , 2003, Nucleic acids research.

[3]  Steffen Jung,et al.  Defining in vivo dendritic cell functions using CD11c-DTR transgenic mice. , 2010, Methods in molecular biology.

[4]  R. Steinman,et al.  In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.

[5]  C. Niemeyer,et al.  Rapid synthesis of DNA-cysteine conjugates for expressed protein ligation. , 2005, Biochemical and biophysical research communications.

[6]  R. Steinman,et al.  Cutting Edge: Langerin/CD207 Receptor on Dendritic Cells Mediates Efficient Antigen Presentation on MHC I and II Products In Vivo1 , 2008, The Journal of Immunology.

[7]  M. Boes,et al.  Antigen cross‐presentation: extending recent laboratory findings to therapeutic intervention , 2011, Clinical and experimental immunology.

[8]  T. Muir,et al.  Expressed protein ligation: a general method for protein engineering. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Akira,et al.  Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity , 2012, PloS one.

[10]  A. Kotlyar,et al.  In vitro synthesis of uniform poly(dG)–poly(dC) by Klenow exo− fragment of polymerase I , 2005, Nucleic acids research.

[11]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[12]  Bali Pulendran,et al.  Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.

[13]  S. Akira,et al.  Toll-like receptor–independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation , 2005, The Journal of experimental medicine.

[14]  P. Bringmann,et al.  Site-specific modification of ED-B-targeting antibody using intein-fusion technology , 2011, BMC biotechnology.

[15]  R. Steinman,et al.  Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine , 2006, The Journal of experimental medicine.

[16]  R. Steinman,et al.  Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A , 2011, Proceedings of the National Academy of Sciences.

[17]  T. Muir,et al.  Streamlined Expressed Protein Ligation Using Split Inteins , 2012, Journal of the American Chemical Society.

[18]  C. Figdor,et al.  Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. , 2011, Blood.

[19]  M. Carrington,et al.  DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes , 2007, Proceedings of the National Academy of Sciences.

[20]  R. Joerger,et al.  High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction. , 1995, Nucleic acids research.

[21]  C. Niemeyer.  Semisynthetic DNA-protein conjugates for biosensing and nanofabrication. , 2010, Angewandte Chemie.

[22]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[23]  T. Muir.  Semisynthesis of proteins by expressed protein ligation. , 2003, Annual review of biochemistry.

[24]  Peter Walden,et al.  Exact prediction of a natural T cell epitope , 1991, European journal of immunology.

[25]  R. Steinman,et al.  Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity , 2012, Journal of internal medicine.

[26]  Tom W Muir,et al.  Protein ligation: an enabling technology for the biophysical analysis of proteins , 2006, Nature Methods.

[27]  R. Yu,et al.  Quantifying small numbers of antibodies with a 'near-universal' protein-DNA chimera , 2007, Nature Methods.

[28]  C R Cantor,et al.  Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. , 1992, Science.

[29]  M. Yoneyama,et al.  NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction1 , 2006, The Journal of Immunology.

[30]  H. Ueno,et al.  Harnessing human dendritic cell subsets for medicine , 2010, Immunological reviews.

[31]  M. Yoneyama,et al.  RNA recognition and signal transduction by RIG‐I‐like receptors , 2009, Immunological reviews.

[32]  Toward the semisynthesis of multidomain transmembrane receptors: Modification of Eph tyrosine kinases , 2008, Protein science : a publication of the Protein Society.

[33]  R. Steinman,et al.  Antibody to Langerin/CD207 localizes large numbers of CD8α+ dendritic cells to the marginal zone of mouse spleen , 2009, Proceedings of the National Academy of Sciences.

[34]  E. Oviedo-Orta,et al.  Progress in understanding adjuvant immunotoxicity mechanisms. , 2011, Toxicology letters.

[35]  R. Steinman,et al.  Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. , 1995, Cellular immunology.

[36]  T. Thai,et al.  Cytosolic DNA-Activated Human Dendritic Cells Are Potent Activators of the Adaptive Immune Response , 2011, The Journal of Immunology.

[37]  R. Steinman,et al.  Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant , 2009, The Journal of experimental medicine.

[38]  Alain Van Dorsselaer,et al.  The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  G. Barber.  Cytoplasmic DNA innate immune pathways , 2011, Immunological Reviews.

[40]  M. Nolte,et al.  Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo , 2007, The Journal of experimental medicine.

[41]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[42]  Gerd R Kleemann,et al.  Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. , 2006, Journal of chromatography. A.

[43]  P. Travers,et al.  The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. , 1998, Journal of immunology.

[44]  C. Coban,et al.  A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.

[45]  T. Ebensen,et al.  Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. , 2009, Advances in experimental medicine and biology.

[46]  A. Levine,et al.  Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group. , 1985, Cancer research.

[47]  V. Hornung,et al.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.

[48]  R. Medzhitov,et al.  Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.

[49]  J. Villadangos,et al.  The cell biology of cross‐presentation and the role of dendritic cell subsets , 2008, Immunology and cell biology.

[50]  Zhijian J. Chen,et al.  RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.

[51]  S. Nutt,et al.  Transcriptional programming of the dendritic cell network , 2012, Nature Reviews Immunology.

[52]  D. Samuel,et al.  Development of a quantitative immuno-PCR assay and its use to detect mumps-specific IgG in serum. , 2002, Journal of immunological methods.

[53]  Tomoki Ito,et al.  Interferon‐α and interleukin‐12 are induced, respectively, by double‐stranded DNA and single‐stranded RNA in human myeloid dendritic cells , 2011, Immunology.

[54]  C. Sousa,et al.  Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function , 2005, Nature Immunology.